Pervasive Developmental Disorder NOS Completed Phase 1 Trials for Mecamylamine (DB00657)

Also known as: Pervasive Developmental Disorder / Pervasive Developmental Disorders / Autistic continuum / Pervasive Development Disorders / Atypical autism / Autism spectrum disorder

IndicationStatusPhase
DBCOND0046531 (Pervasive Developmental Disorder NOS)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00773812Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum DisordersTreatment